The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 1×
“The average particle size of ANG-PEG-NP was about 90 nm, which may accumulate more readily in tumor due to the Enhanced Permeability and Retention (EPR) effect [26,27].”
BackgroundDrug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172
Huang, K., Ma, H., Liu, J., Huo, S., Kumar, A., Wei, T., Zhang, X., Jin, S., Gan, Y., Wang, P. C., et al. (2012) · ACS Nano · doi:10.1021/nn301282m · Cited by 840
Current concepts and management of glioblastoma
Preusser, M., de Ribaupierre, S., Wöhrer, A., Erridge, S. C., Hegi, M., Weller, M., & Stupp, R. (2011) · Annals of Neurology · doi:10.1002/ana.22425 · Cited by 461
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
Ying, X., Wen, H., Lu, W.-L., Du, J., Guo, J., Tian, W., Men, Y., Zhang, Y., Li, R.-J., Yang, T.-Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.020 · Cited by 447
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 447
Xin, H., Jiang, X., Gu, J., Sha, X., Chen, L., Law, K., Chen, Y., Wang, X., Jiang, Y., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.044 · Cited by 384
Self-citationRégina, A., Demeule, M., Ché, C., Lavallée, I., Poirier, J., Gabathuler, R., Béliveau, R., & Castaigne, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.260 · Cited by 368
Li, Y., He, H., Jia, X., Lu, W.-L., Lou, J., & Wei, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.004 · Cited by 310
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Gao, H., Qian, J., Cao, S., Yang, Z., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280
Self-citationDhanikula, R. S., Argaw, A., Bouchard, J.-F., & Hildgen, P. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700086j · Cited by 246
Gene and doxorubicin co-delivery system for targeting therapy of glioma
Liu, S., Guo, Y., Huang, R., Li, J., Huang, S., Kuang, Y., Han, L., & Jiang, C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.031 · Cited by 203
Yan, H., Wang, L., Wang, J., Weng, X., Lei, H., Wang, X., Jiang, L., Zhu, J., Lu, W., Wei, X., et al. (2012) · ACS Nano · doi:10.1021/nn203749v · Cited by 191
Zhu, Z., Li, Y., Li, X., Li, R., Jia, Z., Li, R., Guo, W., Wu, W., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.002 · Cited by 169
Self-citationDing, H., Inoue, S., Ljubimov, A. V., Patil, R., Portilla-Arias, J., Hu, J., Konda, B., Wawrowsky, K. A., Fujita, M., Karabalin, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003919107 · Cited by 168
Du, J., Lü, W.-L., Ying, X., Liu, Y., Du, P., Tian, W. J., Men, Y., Guo, J., Zhang, Y., Li, R., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800218q · Cited by 160
Xin, H., Chen, L., Gu, J., Ren, X., wei, Z., Luo, J., Chen, Y., Jiang, X., Sha, X., & Fang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.005 · Cited by 147
Self-citationXin, H., Sha, X., Jiang, X., Chen, L., Law, K., Gu, J., Chen, Y., Wang, X., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.018 · Cited by 135
Self-citationEngineering a scaffold-free 3D tumor model for in vitro drug penetration studies
Ong, S., Zhao, Z., Arooz, T., Zhao, D., Zhang, S., Du, T., Wasser, M., van Noort, D., & Yu, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.049 · Cited by 134
Desai, A. R., Vyas, T. K., & Amiji, M. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21182 · Cited by 134
Ong, B. Y. S., Ranganath, S. H., Lee, L. Y., Fan, L., Lee, H. S., Sahinidis, N. V., & Wang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.030 · Cited by 132
Binding and interstitial penetration of liposomes within avascular tumor spheroids
Kostarelos, K., Emfietzoglou, D., Papakostas, A., Yang, W., Ballangrud, Å., & Sgouros, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20457 · Cited by 127
Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo
Zhan, C., Wei, X., Qian, J., Feng, L., Zhu, J., & Lu, W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.022 · Cited by 112
Adam, J., Joubert, A., Biston, M., Charvet, A., Péoc’h, M., Bas, J. L., Balosso, J., Estève, F., & Elleaume, H. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.09.004 · Cited by 85
Chekhonin, V. P., Baklaushev, V. P., Yusubalieva, G. M., Belorusova, A. E., Gulyaev, M. V., Tsitrin, E. B., Grinenko, N. F., Gurina, O. I., & Pirogov, Y. A. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.011 · Cited by 72
Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats
Tian, W. J., Ying, X., Du, J., Guo, J., Men, Y., Zhang, Y., Li, R., Yao, H.-J., Lou, J., Zhang, L., et al. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.06.008 · Cited by 62
Growth and characterization of LNCaP prostate cancer cell spheroids.
Ballangrud, Å., Yang, W., Dnistrian, A. M., Lampen, N., & Sgouros, G. (1999) · PubMed · Cited by 51
Chemotherapy and novel therapeutic approaches in malignant gliomas
Desjardins, A. (2005) · Frontiers in bioscience · doi:10.2741/1727 · Cited by 50
Bahmani, P., Schellenberger, E. A., Klohs, J., Steinbrink, J. M., Cordell, R., Zille, M., Müller, J. M., Harhausen, D., Hofstra, L., Reutelingsperger, C. P. M., et al. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.233 · Cited by 43
Antibody-Targeted Nanovectors for the Treatment of Brain Cancers
Sharpe, M. A., Marcano, D. C., Berlin, J. M., Widmayer, M. A., Baskin, D. S., & Tour, J. M. (2012) · ACS Nano · doi:10.1021/nn2048679 · Cited by 26
Cited by
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
Grossen, P., Witzigmann, D., Sieber, S., & Huwyler, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.028 · Cited by 496
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Metadata
- Authors
- Xin, H., Sha, X., Jiang, X., Zhang, W., Chen, L., & Fang, X.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 33
- Issue
- 32
- Pages
- 8167-8176
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2004049846
- Cited by
- 311
- References
- 32
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.